全球家禽疫苗市場:按疾病、技術(活疫苗、重組疫苗、滅活疫苗、其他技術)、地區 - 規模、份額、前景、機會分析,2023-2030 年
市場調查報告書
商品編碼
1233321

全球家禽疫苗市場:按疾病、技術(活疫苗、重組疫苗、滅活疫苗、其他技術)、地區 - 規模、份額、前景、機會分析,2023-2030 年

Poultry Vaccine Market, By Disease, By Technology (Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines, and Other Technologies), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

疫苗通過增強鳥類的免疫系統產生抗體來對抗各種生物和疾病,從而幫助預防某些疾病。 家禽疫苗可幫助鳥類增強對病原體的免疫力並保護它們免受疾病侵害。

市場動態

人畜共患疾病流行率/發病率上升、家禽數量不斷增加、對安全有效家禽的需求增加、對食品安全的關注日益增加、一些政府機構和動物預測期內全球家禽疫苗市場。

例如,2022 年 10 月,Zoetis 宣布推出 Poulvac Procerta HVT-IBD,這是一種重組載體疫苗,可在單劑中提供針對馬立克氏病、傳染性滑囊炎和新城疫病毒的早期和強有力的保護。-將 ND 引入到擴大家禽疫苗組合。

此外,2019 年 9 月,勃林格殷格翰將利用其在法國獸醫公共衛生 (VPH) 領域的開創性專業知識,開發歐洲最大的動物疫苗生產生物技術生產基地。該基地已啟動。

這項研究的主要特點

  • 本報告對全球家禽疫苗市場進行了深入分析,提供了以 2022 年為基準年的預測期(2023-2030 年)的市場規模(美國)和復合年增長率 (CAGR%)。做。
  • 它還闡明了各個細分市場的潛在創收機會,並概述了針對該市場的一系列有吸引力的投資建議。
  • 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
  • 它根據以下參數介紹了全球家禽疫苗市場的主要參與者,包括公司亮點、產品組合、主要亮點、財務業績和戰略。
  • 本研究涵蓋的主要公司包括 Zoetis Inc.、Merck & Co.、Elanco、Ceva Sante Animale、Boehringer Ingelheim、Biovac、Hester Biosciences Limited、Dechra Pharmaceuticals PLC、Venky's Limited 和 Phibro Animal Health Corporation。
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 《全球家禽疫苗市場》報告面向該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球家禽疫苗市場的各種戰略矩陣來促進他們的決策。

這是目錄。

第一章調查的目的和前提

  • 調查目的
  • 先決條件
  • 縮寫

第二章市場範圍

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況:按疾病分類
    • 市場概況:按技術分類
    • 市場概況:按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 人畜共患疾病負擔加重,家禽數量不斷增加
    • 動物試驗和獸醫費用高昂
    • 對安全有效的家禽疫苗的需求不斷增加
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/批准
  • 害蟲分析
  • 對 PORTER 的分析
  • 合併/收購場景

第 4 章全球家禽疫苗市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • COVID-19 流行病學
  • 供應方和需求方分析
  • 經濟影響

第 5 章全球家禽疫苗市場,按疾病分類,2017-2030

  • 支氣管炎
  • 禽流感
  • 新城疫
  • 其他疾病

第 6 章全球家禽疫苗市場,按技術分類,2017-2030

  • 有人值守的疫苗 (LAV)
  • 重組疫苗
  • 滅活□□疫苗
  • 其他技術

第 7 章:2017-2030 年按地區分列的全球家禽疫苗市場

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
  • 世界其他地方

第八章競爭格局

  • Zoetis Inc.
  • Merck & Co. Inc.
  • Elanco
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Biovac
  • Hester Biosciences Limited
  • Dechra Pharmaceuticals PLC
  • Venky's Limited
  • Phibro Animal Health Corporation

第 9 章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5527

Vaccines help to prevent any particular disease by boosting the bird's immune system to produce antibodies, which in turn, fight against a variety of organisms and diseases. A poultry vaccine help bird develop immunity to pathogens and protect them against a disease.

Market Dynamics:

Rise in prevalence/incidence of zoonotic diseases, rise in poultry population, increase in demand for safe/effective poultry, widened focus on food safety, and favorable initiatives taken by several government agencies and animal associations are major factors expected to augment growth of the global poultry vaccine market during the forecast period.

For instance, in October 2022, Zoetis expanded its poultry vaccine portfolio with the introduction of Poulvac Procerta HVT-IBD-ND, a recombinant vector vaccine which provides early and robust protection against Marek's, infectious bursal and Newcastle disease viruses with one dose.

Moreover, in September 2019, Boehringer Ingelheim started developing the largest biotechnology production sites for the veterinary vaccine production in Europe, building on France's pioneering expertise in veterinary public health (VPH).

Key features of the study:

  • This report provides in-depth analysis of the global poultry vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global poultry vaccine market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Zoetis Inc., Merck & Co., Elanco, Ceva Sante Animale, Boehringer Ingelheim, Biovac, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Venky's Limited, and Phibro Animal Health Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global poultry vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry vaccine market.

Detailed Segmentation:

  • Global Poultry Vaccine Market, By Disease:
    • Bronchitis
    • Avian Influenza
    • Newcastle disease
    • Marek's Disease
    • Other Diseases
  • Global Poultry Vaccine Market, By Technology:
    • Live Attenuated Vaccines (LAV)
    • Recombinant Vaccines
    • Inactivated Vaccines
    • Other Technologies
  • Global Poultry Vaccine Market, By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Middle East and Africa
    • South America
  • Company Profiles:
    • Zoetis Inc.
    • Merck & Co. Inc.
    • Elanco
    • Ceva Sante Animale
    • Boehringer Ingelheim
    • Biovac
    • Hester Biosciences Limited
    • Dechra Pharmaceuticals PLC
    • Venky's Limited
    • Phibro Animal Health Corporation

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Disease
    • Market Snapshot, By Technology
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of zoonotic diseases and rise in poultry population
    • High cost of animal testing and veterinary services
    • Increase in demand for safe and effective poultry vaccine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Poultry Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Poultry Vaccine Market, By Disease, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Bronchitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Avian Influenza
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Newcastle disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
    • Marek's Disease
  • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Other Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Poultry Vaccine Market, By Technology, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Live Attenuated Vaccines (LAV)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Recombinant Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Inactivated Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Poultry Vaccine Market, By Geography, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

8. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva Sante Animale
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Biovac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hester Biosciences Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dechra Pharmaceuticals PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Venky's Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us